cbdMD, Inc. (YCBD)
0.8063
-0.11
(-12.05%)
USD |
NYAM |
Mar 02, 15:59
cbdMD EPS Diluted (Quarterly) : -0.036 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cassava Sciences, Inc. | -0.2237 |
| NovaBay Pharmaceuticals, Inc. | -1.100 |
| Elite Pharmaceuticals, Inc. | 0.0059 |
| Glaukos Corp. | -2.324 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2831M |
| Revenue (Quarterly) | 5.017M |
| Total Expenses (Quarterly) | 5.30M |
| Enterprise Value | 5.374M |
| Gross Profit Margin (Quarterly) | 54.93% |
| Profit Margin (Quarterly) | -5.64% |
| Earnings Yield | -276.3% |
| Normalized Earnings Yield | -276.00 |